onr:"swepub:oai:DiVA.org:uu-104052"
Search: onr:"swepub:oai:DiVA.org:uu-104052" > Increased proportio...
- 1 of 1
- Previous record
- Next record
- To hitlist
- Schepis, DanikaKarolinska Institutet (author)
Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus
- Article/chapterEnglish2009
Publisher, publication year, extent ...
- Wiley,2009
- printrdacarrier
Numbers
- LIBRIS-ID:oai:DiVA.org:uu-104052
- https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-104052URI
- https://doi.org/10.1111/j.1365-2567.2008.02887.xDOI
- http://kipublications.ki.se/Default.aspx?queryparsed=id:117948351URI
Supplementary language notes
- Language:English
- Summary in:English
Part of subdatabase
- SwePubSwePub
Classification
Notes
- Natural killer (NK) cells belong to the innate immune system but can also affect adaptive immune reactions. This immune regulatory function is often ascribed to the CD56(bright) subpopulation of NK cells that is prevalent in secondary lymphoid tissues and has potent cytokine-producing ability. The NK cells have been described as affecting autoimmune disease and stimulating B-cell production of antibodies, but their role in systemic lupus erythematosus (SLE) pathology has not been extensively studied. We have studied NK cells in SLE, a B-cell-driven systemic autoimmune disease, and phenotypically characterized peripheral blood NK cells in comparison to NK cells from patients with immunoglobulin A nephritis, rheumatoid arthritis and healthy individuals. We have found an increased proportion of CD56(bright) NK cells in SLE, regardless of disease activity. We detected a somewhat increased expression of the activating receptor NKp46/CD335 on NK cells from SLE patients, although neither the percentage of NK cells of all lymphocytes nor the expression of other NK receptors analysed (LIR-1/CD85j, CD94, NKG2C/CD159c, NKG2D/CD314, NKp30/CD337, NKp44/CD336, CD69) differed between patient groups. We show that type I interferon, a proinflammatory cytokine known to be abundant in SLE, can cause increases of CD56(bright) NK cells in vitro. We confirmed that serum levels of interferon-alpha were increased in active, but not in inactive, disease in the SLE patient group. In conclusion, we found an increased proportion of CD56(bright) NK cells in the blood of SLE patients, although it remains to be examined whether and how this relates to the disease process.
Subject headings and genre
- NK cells
- type I IFN
- interferon
- MEDICINE
- MEDICIN
Added entries (persons, corporate bodies, meetings, titles ...)
- Gunnarsson, IvaKarolinska Institutet (author)
- Eloranta, Maija-LeenaUppsala universitet,Institutionen för medicinska vetenskaper,Systemic Autoimmunity(Swepub:uu)maelo020 (author)
- Lampa, JonKarolinska Institutet (author)
- Jacobson, Stefan H.Karolinska Institutet (author)
- Kärre, KlasKarolinska Institutet (author)
- Berg, LouiseKarolinska Institutet (author)
- Karolinska InstitutetInstitutionen för medicinska vetenskaper (creator_code:org_t)
Related titles
- In:Immunology: Wiley126:1, s. 140-60019-28051365-2567
Internet link
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Schepis, Danika
- Gunnarsson, Iva
- Eloranta, Maija- ...
- Lampa, Jon
- Jacobson, Stefan ...
- Kärre, Klas
- show more...
- Berg, Louise
- show less...
- Articles in the publication
- Immunology
- By the university
- Uppsala University
- Karolinska Institutet
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
